+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ablynx  - logo

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

From
From
From
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • October 2016
  • 59 pages
From
From
Prefilled Syringes Market (5th Edition), 2020-2030 - Product Thumbnail Image

Prefilled Syringes Market (5th Edition), 2020-2030

  • Report
  • January 2020
  • 554 Pages
From
From
Post Menopausal Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 131 pages
From
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 pages
From
From
From
From
Loading Indicator
adroll